Biomol Ther.  2017 Jan;25(1):69-79. 10.4062/biomolther.2016.208.

US28, a Virally-Encoded GPCR as an Antiviral Target for Human Cytomegalovirus Infection

Affiliations
  • 1College of Pharmacy, Dongguk University, Goyang 10326, Republic of Korea. choongholee@dongguk.edu
  • 2Department of Anatomy, College of Medicine, Chung-Ang University, Seoul 06974, Republic of Korea.

Abstract

Viruses continue to evolve a new strategy to take advantage of every aspect of host cells in order to maximize their survival. Due to their central roles in transducing a variety of transmembrane signals, GPCRs seem to be a prime target for viruses to pirate for their own use. Incorporation of GPCR functionality into the genome of herpesviruses has been demonstrated to be essential for pathogenesis of many herpesviruses-induced diseases. Here, we introduce US28 of human cytomegalovirus (HCMV) as the best-studied example of virally-encoded GPCRs to manipulate host GPCR signaling. In this review, we wish to summarize a number of US28-related topics including its regulation of host signaling pathways, its constitutive internalization, its structural and functional analysis, its roles in HCMV biology and pathogenesis, its proliferative activities and role in oncogenesis, and pharmacological modulation of its biological activities. This review will aid in our understanding of how pathogenic viruses usurp the host GPCR signaling for successful viral infection. This kind of knowledge will enable us to build a better strategy to control viral infection by normalizing the virally-dysregulated host GPCR signaling.

Keyword

G protein-coupled receptor; Human cytomegalovirus; US28; Virally-encoded G protein-coupled receptor; Chemokine receptor; Antiviral target

MeSH Terms

Biology
Carcinogenesis
Cytomegalovirus Infections*
Cytomegalovirus*
Genome
Herpesviridae
Humans*
Full Text Links
  • BT
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr